From: Novel PET imaging biomarkers as predictors of postoperative recurrence in lung adenocarcinoma
Parameter | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
P-value | Odds ratio (95% CI) | P-value | Odds ratio (95% CI) | |
NHOPmax | < 0.001 | 0.033 (0.015–0.075) | 0.002 | 0.035 (0.006–0.210) |
NHOCmax | < 0.001 | 0.112 (0.063–0.200) | 0.951 | 0.958 (0.308–2.989) |
T Stage | < 0.001 | 0.461 (0.374–0.567) | 0.109 | 0.496 (0.242–1.018) |
Operation | < 0.001 | 0.446 (0.357–0.557) | 0.759 | 1.074 (0.733–1.573) |
Adjuvant Therapy | 0.192 | 0.628(0.349–1.130) | ||
Stage | < 0.001 | 0.623 (0.506–0.767) | 0.528 | 1.163 (0.785–1.723) |
MTV | 0.028 | 0.948 (0.910–0.987) | 0.153 | 1.030 (0.996–1.065) |
SUVmax | < 0.001 | 0.894 (0.859–0.930) | 0.036 | 1.100 (1.020–1.186) |
TLG | 0.648 | 0.999(0.996–1.002) | ||
N Stage | 0.079 | 0.578 (0.346–0.967) | ||
CEA | 0.851 | 0.999(0.991–1.007) |